Download
fimmu-12-547333.pdf 7,13MB
WeightNameValue
1000 Titel
  • The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model
1000 Autor/in
  1. Yan, Tao |
  2. Ma, Guoyuan |
  3. Wang, Kai |
  4. Liu, Weidong |
  5. Zhong, Weiqing |
  6. Du, Jiajun |
1000 Verlag
  • Frontiers Media S.A.
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-29
1000 Erschienen in
1000 Quellenangabe
  • 12:547333
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-31
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fimmu.2021.547333 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358782/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>Adenocarcinoma (AD) and squamous cell carcinoma (SCC) are both classified as major forms of non-small cell lung cancer, but differences in clinical prognoses and molecular mechanisms are remarkable. Recent studies have supported the importance of understanding immune status in that it influences clinical outcomes of cancer, and immunotherapies based on the theory of “immune editing” have had notable clinical success. Our study aimed to identify specific long non-coding (lnc) RNAs that control key immune-related genes and to use them to construct risk models for AD and SCC. Risk scores were used to separate patients into high- and low-risk groups, and we validated the prognostic significance of both risk scores with our own cohorts. A Gene Set Enrichment Analysis suggested that the immune responses of patients in the AD high-risk group and the SCC low-risk group tended to be weakened. Evaluation of immune infiltration revealed that the degree of infiltration of dendritic cells is of particular importance in AD. In addition, prediction of responses to immune checkpoint inhibitor (ICI) treatments, based on the T Cell Immune Dysfunction and Exclusion and immunophenoscore models, indicated that deterioration of the immune microenvironment is due mainly to T cell exclusion in AD patients and T cell dysfunction in SCC patients and that high-risk patients with SCC might benefit from ICI treatment. The prediction of downstream targets <jats:italic>via</jats:italic> The Cancer Proteome Atlas and RNA-seq analyses of a transfected lung cancer cell line indicated that the lncRNA LINC00996 is a potential therapeutic target in AD.</jats:p>
1000 Sacherschließung
lokal Carcinoma, Squamous Cell/mortality [MeSH]
lokal long non-coding RNAs
lokal Models, Immunological [MeSH]
lokal Lung Neoplasms/genetics [MeSH]
lokal immune
lokal RNA, Long Noncoding/genetics [MeSH]
lokal Risk [MeSH]
lokal Cohort Studies [MeSH]
lokal squamous cell carcinoma
lokal Adenocarcinoma/immunology [MeSH]
lokal Lung Neoplasms/immunology [MeSH]
lokal Carcinoma, Squamous Cell/immunology [MeSH]
lokal Cellular Senescence/genetics [MeSH]
lokal Immunity/genetics [MeSH]
lokal A549 Cells [MeSH]
lokal Immunology
lokal Lung Neoplasms/mortality [MeSH]
lokal RNA, Long Noncoding/immunology [MeSH]
lokal T-Lymphocytes/immunology [MeSH]
lokal Humans [MeSH]
lokal Survival Analysis [MeSH]
lokal Molecular Targeted Therapy [MeSH]
lokal adenocarcinoma
lokal Adenocarcinoma/genetics [MeSH]
lokal non-small cell lung cancer
lokal Carcinoma, Squamous Cell/genetics [MeSH]
lokal Adenocarcinoma/mortality [MeSH]
lokal Tumor Microenvironment [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/WWFuLCBUYW8=|https://frl.publisso.de/adhoc/uri/TWEsIEd1b3l1YW4=|https://frl.publisso.de/adhoc/uri/V2FuZywgS2Fp|https://frl.publisso.de/adhoc/uri/TGl1LCBXZWlkb25n|https://frl.publisso.de/adhoc/uri/WmhvbmcsIFdlaXFpbmc=|https://frl.publisso.de/adhoc/uri/RHUsIEppYWp1bg==
1000 Hinweis
  • DeepGreen-ID: c22e9b34f9364b76a1ed3f3ce6a5ec68 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. National Natural Science Foundation of China |
  2. Natural Science Foundation of Shandong Province |
  3. Key Technology Research and Development Program of Shandong Province |
1000 Fördernummer
  1. -
  2. -
  3. -
1000 Förderprogramm
  1. -
  2. -
  3. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Natural Science Foundation of China |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Natural Science Foundation of Shandong Province |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Key Technology Research and Development Program of Shandong Province |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6478835.rdf
1000 Erstellt am 2024-05-21T17:57:16.735+0200
1000 Erstellt von 322
1000 beschreibt frl:6478835
1000 Zuletzt bearbeitet 2024-05-22T11:56:14.807+0200
1000 Objekt bearb. Wed May 22 11:56:14 CEST 2024
1000 Vgl. frl:6478835
1000 Oai Id
  1. oai:frl.publisso.de:frl:6478835 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source